CDC Trial Gel to Prevent HIV in Women
CDC reports promising results from CAPRISA microbicide trial showing tenofovir-based vaginal gel may help women prevent HIV infection and reduce genital herpes risk.
CDC reports promising results from CAPRISA microbicide trial showing tenofovir-based vaginal gel may help women prevent HIV infection and reduce genital herpes risk.
CDC urges all Americans aged 13-64 to get tested for HIV on National HIV Testing Day. Over 200,000 people are living with HIV unknowingly in the US.